Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Oxygen Gas for Inhalation

PreclinicalSmall molecule

OOttawa Hospital Research Institute

1

Indications

2

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[3][1]

Indication

Inflammatory Bowel Disease (IBD)Not yet recruiting

Inflammatory Bowel Disease (IBD)Preclinical

Not yet recruiting

Timeline

Expected Milestones

Q1 2028

PreclinicalNot yet recruiting

Inflammatory Bowel Disease (IBD)

NCT06109961

Clinical

Trials by Indication[1]

Pain Management1 trial

Nitrous Oxide for Pain Management During IUD Insertion in Nulliparous Adolescent Women

Withdrawn·—·Phase 2/3·NCT04089852

Inflammatory Bowel Disease (IBD)1 trial

Hyperbaric Oxygen Therapy for Perianal Fistulizing Crohn's Disease Not Responsive or Intolerant to Conventional Care: HYPNOTIC Pilot Study

Not yet recruiting·OOttawa Hospital Research Institute·Preclinical·NCT06109961·54 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Oxygen Gas for Inhalation. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Oxygen Gas for Inhalation compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Oxygen Gas for Inhalation. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Ottawa Hospital Research Institute company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: OOttawa Hospital Research Institute

Related News